Accountable Care OrganizationsAmbulatory Procedure/Imaging CenterAmbulatory/Office-based CareAncillary ServicesAssisted Living FacilitiesBehavioral Health CareCommunity Health CareEmergency DepartmentEmergency Medical ServicesHome CareHospicesHospital InpatientHospital OutpatientHospital â OtherIntensive Care UnitsLong-term Care Facilities - OtherManaged Care PlansNational Public Health ProgramsOtherPatient-centered Medical HomesRegional, County, or City Public Health ProgramsRehabilitation CentersResidential Care FacilitiesRural Health CareSkilled Nursing Facilities/Nursing HomesState/Provincial Public Health ProgramsSubstance Use Treatment Programs/CentersTransitionUnspecified
Lymphoma: proportion of patients with follicular lymphoma and diffuse large B cell lymphoma (DLBCL) who receive chemotherapy in combination with rituximab.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with lymphoma who are discussed at a multidisciplinary team (MDT) meeting within 6 weeks of diagnosis.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL) undergoing treatment with curative intent who have MYC testing prior to treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with classical Hodgkin lymphoma (CHL) undergoing treatment with curative intent who undergo PET CT prior to treatment and within 2 weeks of radiology request.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with classical Hodgkin lymphoma (CHL) undergoing treatment with curative intent who undergo PET CT prior to treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with diffuse large B cell lymphoma (DLBCL) who are undergoing chemotherapy treatment with curative intent who undergo CT of chest, abdomen and pelvis or PET CT at end of chemotherapy treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with lymphoma undergoing treatment with curative intent who undergo CT of chest, abdomen and pelvis or PET CT scanning prior to treatment and within 2 weeks of radiology request.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lymphoma: proportion of patients with lymphoma undergoing treatment with curative intent who undergo CT of chest, abdomen and pelvis or PET CT scanning prior to treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer who are enrolled in an interventional clinical trial or translational research.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer who die within 30 days of chemotherapy treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with triple negative breast cancer under 40 years of age referred to a specialist clinic for genetic testing.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer under 30 years of age referred to a specialist clinic for genetic testing.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer (invasive or in-situ) having breast conservation surgery who undergo re-excision or mastectomy following initial breast surgery.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with invasive breast cancer who have a greater than or equal to 5% overall survival benefit of chemotherapy treatment predicted at 10 years that undergo adjuvant chemotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer having conservation surgery who receive radiotherapy to the breast.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with invasive breast cancer for whom the HER2 status (as detected by immunohistochemistry analysis) is reported within 2 weeks of core biopsy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients undergoing wide excision and/or an axillary sampling procedure for breast cancer as day case surgery.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer who undergo immediate breast reconstruction at the time of mastectomy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of patients with breast cancer (invasive or ductal carcinoma in-situ) having breast conservation surgery with final radial excision margins of less than 1 mm.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Breast cancer: proportion of surgically treated patients with breast cancer less than 20 mm whole tumour size on histology (invasive plus in-situ disease) treated by breast conservation surgery.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
